Design, development, and technical considerations for dry powder inhaler devices

被引:4
|
作者
Dhoble, Sagar [1 ]
Kapse, Archana [1 ]
Ghegade, Vaibhav [1 ]
Chogale, Manasi [1 ]
Ghodake, Vinod [1 ]
Patravale, Vandana [1 ]
Vora, Lalitkumar K. [2 ]
机构
[1] Inst Chem Technol, Dept Pharmaceut Sci & Technol, Mumbai 400019, India
[2] Queens Univ Belfast, Sch Pharm, Belfast, North Ireland
关键词
COMPUTATIONAL FLUID-DYNAMICS; DRUG-DELIVERY; PERFORMANCE; DEPOSITION; ROUGHNESS; THERAPY; SULFATE; LACTOSE; SIZE;
D O I
10.1016/j.drudis.2024.103954
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The dry powder inhaler (DPI) stands out as a highly patient-friendly and effective pulmonary formulation, surpassing traditional and other pulmonary dosage forms in certain disease conditions. The development of DPI products, however, presents more complexities than that of other dosage forms, particularly in device design and the integration of the drug formulation. This review focuses on the capabilities of DPI devices in pulmonary drug delivery, with a special emphasis on device design and formulation development. It also discusses into the principles of deep lung particle deposition and device engineering, and provides a current overview of the market for DPI devices. Furthermore, the review highlights the use of computational fluid dynamics (CFD) in DPI product design and discusses the regulatory environment surrounding these devices.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] A preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: A technical note
    Shahiwala, A
    Misra, A
    AAPS PHARMSCITECH, 2005, 6 (03):
  • [22] Development of spray dried liposomal dry powder inhaler of Dapsone
    Chougule, Mahavir
    Padhi, Bijay
    Misra, Ambikanandan
    AAPS PHARMSCITECH, 2008, 9 (01) : 47 - 53
  • [23] Development of Liposomal Salbutamol Sulfate Dry Powder Inhaler Formulation
    Huang, Wen-Hua
    Yang, Zhi-Jun
    Wu, Heng
    Wong, Yuen-Fan
    Zhao, Zhong-Zhen
    Liu, Liang
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2010, 33 (03) : 512 - 517
  • [24] Development of dry powder inhaler formulations for drug delivery systems
    Akdag, Yagmur
    JOURNAL OF RESEARCH IN PHARMACY, 2019, 23 (06): : 973 - 987
  • [25] Development of liposomal amphotericin B dry powder inhaler formulation
    Shah, SP
    Misra, A
    DRUG DELIVERY, 2004, 11 (04) : 247 - 253
  • [26] Development of Spray Dried Liposomal Dry Powder Inhaler of Dapsone
    Mahavir Chougule
    Bijay Padhi
    Ambikanandan Misra
    AAPS PharmSciTech, 2008, 9 : 47 - 53
  • [27] The Genuair® inhaler: a novel, multidose dry powder inhaler
    Chrystyn, H.
    Niederlaender, C.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (03) : 309 - 317
  • [28] Kinetics of emitted mass-A study with three dry powder inhaler devices
    Behara, Srinivas Ravindra Babu
    Kippax, Paul
    Larson, Ian
    Morton, David A. V.
    Stewart, Peter
    CHEMICAL ENGINEERING SCIENCE, 2011, 66 (21) : 5284 - 5292
  • [29] Effect of Inhaler Design Variables on Paediatric Use of Dry Powder Inhalers
    Lexmond, Anne J.
    Kruizinga, Tonnis J.
    Hagedoorn, Paul
    Rottier, Bart L.
    Frijlink, Henderik W.
    de Boer, Anne H.
    PLOS ONE, 2014, 9 (06):
  • [30] Handling of inhaler devices in actual pulmonary practice: Metered-dose inhaler versus dry powder inhalers
    Khassawneh, Basheer Y.
    Al-Ali, Musa K.
    Alzoubi, Karem H.
    Batarseh, Morad Z.
    Al-Safi, Saafan A.
    Sharara, Abdelmonem M.
    Alnasr, Hatem M.
    RESPIRATORY CARE, 2008, 53 (03) : 324 - 328